Cell-based therapies for Parkinson’s disease

References

• Parkinson J. An essay on the shaking palsy. J. Neuropsychiatry Clin. Neurosci.14(2), 223–236 (2002).
   PubMed Web of Science ®Google Scholar
• Owen AM. Cognitive dysfunction in Parkinson’s disease: the role of frontostriatal circuitry. Neuroscientist10(6), 525–537 (2004).
   PubMed Web of Science ®Google Scholar
• Kulisevsky J, Pagonabarraga J, Pascual-Sedano B, García-Sánchez C, Gironell A. Prevalence and correlates of neuropsychiatric symptoms in Parkinson’s disease without dementia. Mov. Disord.23(13), 1889–1896 (2008).
   PubMed Web of Science ®Google Scholar
• Lees AJ, Selikhova M, Andrade LA, Duyckaerts C. The black stuff and Konstantin Nikolaevich Tretiakoff. Mov. Disord.23(6), 777–783 (2008).
   PubMed Web of Science ®Google Scholar
• Hornykiewicz O. The discovery of dopamine deficiency in the Parkinsonian brain. In: Parkinson’s Disease and Related Disorders. Riederer P, Reichmann H, Youdim MBH, Gerlach M (Eds). Springer, Vienna, Austria, 9–15 (2006).
   Google Scholar
• Carlsson A, Lindqvist M, Magnusson TOR. 3,4-dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature180(4596), 1200 (1957).
   PubMed Web of Science ®Google Scholar
• Rosegay H. An experimental investigation of the connections between the corpus striatum and substantia nigra in the cat. J. Comp. Neurol.80(3), 293–321 (1944).
   Google Scholar
• Andén NE, Carlsson A, Dahlström A, Fuxe K, Hillarp NÅ, Larsson K. Demonstration and mapping out of nigro-neostriatal dopamine neurons. Life Sci.3(6), 523–530 (1964).
   Web of Science ®Google Scholar
• Andén NE, Dahlström A, Fuxe K, Larsson K. Further evidence for the presence of nigro-neostriatal dopamine neurons in the rat. Am. J. Anat.116(1), 329–333 (1965).
   PubMedGoogle Scholar
• Lim SY, Lang AE. The nonmotor symptoms of Parkinson’s disease – an overview. Mov. Disord.25(S1), S123–S130 (2010).
   PubMed Web of Science ®Google Scholar
• Lauder JM, Bloom FE. Ontogeny of monoamine neurons in the locus coeruleus, raphe nuclei and substantia nigra of the rat. J. Comp. Neurol.163(3), 251–264 (1975).
   PubMedGoogle Scholar
• Specht LA, Pickel VM, Joh TH, Reis DJ. Light-microscopic immunocytochemical localization of tyrosine hydroxylase in prenatal rat brain. II. Late ontogeny. J. Comp. Neurol.199(2), 255–276 (1981).
   PubMedGoogle Scholar
• Perlow MJ, Freed WJ, Hoffer BJ, Seiger A, Olson L, Wyatt RJ. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science204(4393), 643–647 (1979).
   PubMed Web of Science ®Google Scholar
• Björklund A, Stenevi U. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res.177(3), 555–560 (1979).
   PubMed Web of Science ®Google Scholar
• Björklund A, Schmidt RH, Stenevi U. Functional reinnervation of the neostriatum in the adult rat by use of intraparenchymal grafting of dissociated cell suspensions from the substantia nigra. Cell Tissue Res.212(1), 39–45 (1980).
   PubMed Web of Science ®Google Scholar
• Madrazo I, Leon V, Torres C et al. Transplantation of fetal substantia nigra and adrenal medulla to the caudate nucleus in two patients with Parkinson’s disease. N. Engl. J. Med.318(1), 51 (1988).
   PubMed Web of Science ®Google Scholar
• Lindvall O, Rehncrona S, Brundin P et al. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson’s disease: a detailed account of methodology and a 6-month follow-up. Arch. Neurol.46(6), 615–631 (1989).
   PubMed Web of Science ®Google Scholar
• Lindvall O, Gustavii B, Åstedt B et al. Fetal dopamine-rich mesencephalic grafts in Parkinson’s disease. Lancet332(8626–8627), 1483–1484 (1988).
   Google Scholar
• Lindvall O, Brundin P, Widner H et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson’s disease. Science247(4942), 574–577 (1990).
   PubMed Web of Science ®Google Scholar
• Lindvall O, Sawle G, Widner H et al. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson’s disease. Ann. Neurol.35(2), 172–180 (1994).
   PubMed Web of Science ®Google Scholar
• Piccini P, Pavese N, Hagell P et al. Factors affecting the clinical outcome after neural transplantation in Parkinson’s disease. Brain128(12), 2977–2986 (2005).
   PubMed Web of Science ®Google Scholar
• Freed CR, Greene PE, Breeze RE et al. Transplantation of embryonic dopamine neurons for severe Parkinson’s disease. N. Engl. J. Med.344(10), 710–719 (2001).
   PubMed Web of Science ®Google Scholar
• Olanow CW, Goetz CG, Kordower JH et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson’s disease. Ann. Neurol.54(3), 403–414 (2003).
   PubMed Web of Science ®Google Scholar
• Ma Y, Tang C, Chaly T et al. Dopamine cell implantation in Parkinson’s disease: long-term clinical and 18F-FDOPA PET outcomes. J. Nucl. Med.51(1), 7–15 (2010).
   PubMed Web of Science ®Google Scholar
• Hagell P, Schrag A, Piccini P et al. Sequential bilateral transplantation in Parkinson’s disease: effects of the second graft. Brain122(6), 1121–1132 (1999).
   PubMed Web of Science ®Google Scholar
• Brundin P, Pogarell O, Hagell P et al. Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson’s disease. Brain123(7), 1380–1390 (2000).
   PubMed Web of Science ®Google Scholar
• Polgar S, Morris ME, Reilly S, Bilney B, Sanberg PR. Reconstructive neurosurgery for Parkinson’s disease: a systematic review and preliminary meta-analysis. Brain Res. Bull.60(1–2), 1–24 (2003).
   PubMedGoogle Scholar
• Graff-Radford J, Foote KD, Rodriguez RL et al. Deep brain stimulation of the internal segment of the globus pallidus in delayed runaway dyskinesia. Arch. Neurol.63(8), 1181–1184 (2006).
   PubMedGoogle Scholar
• Herzog J, Pogarell O, Pinsker MO et al. Deep brain stimulation in Parkinson’s disease following fetal nigral transplantation. Mov. Disord.23(9), 1293–1296 (2008).
   PubMedGoogle Scholar
• Carlsson T, Carta M, Munoz A et al. Impact of grafted serotonin and dopamine neurons on development of L-dopa-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration. Brain132(2), 319–335 (2009).
   PubMedGoogle Scholar
• Politis M, Wu K, Loane C et al. Serotonergic neurons mediate dyskinesia side effects in Parkinson’s patients with neural transplants. Sci. Transl. Med.2(38), 38ra46 (2010).
   PubMed Web of Science ®Google Scholar
• Barker RA, Kuan W-L. Graft-induced dyskinesias in Parkinson’s disease: what is it all about? Cell Stem Cell7(2), 148–149 (2010).
   PubMedGoogle Scholar
• Ma Y, Feigin A, Dhawan V et al. Dyskinesia after fetal cell transplantation for parkinsonism: a PET study. Ann. Neurol.52(5), 628–634 (2002).
   PubMed Web of Science ®Google Scholar
• Maries E, Kordower JH, Chu Y et al. Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats. Neurobiol. Dis.21(1), 165–180 (2006).
   PubMedGoogle Scholar
• Carlsson T, Winkler C, Lundblad M, Cenci MA, Björklund A, Kirik D. Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia. Neurobiol. Dis.21(3), 657–668 (2006).
   PubMed Web of Science ®Google Scholar
• Wurtman RJ, Pohorecky LA, Baliga BS. Adrenocortical control of the biosynthesis of epinephrine and proteins in the adrenal medulla. Pharmacol. Rev.24(2), 411–426 (1972).
   PubMed Web of Science ®Google Scholar
• Freed WJ, Morihisa JM, Spoor E et al. Transplanted adrenal chromaffin cells in rat brain reduce lesion-induced rotational behaviour. Nature292(5821), 351–352 (1981).
   PubMedGoogle Scholar
• Backlund E-O, Granberg P-O, Hamberger B et al. Transplantation of adrenal medullary tissue to striatum in Parkinsonism. J. Neurosurg.62(2), 169–173 (1985).
   PubMed Web of Science ®Google Scholar
• Madrazo I, Drucker-Colín R, Díaz V, Martínez-Mata J, Torres C, Becerril JJ. Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson’s disease. N. Engl. J. Med.316(14), 831–834 (1987).
   PubMed Web of Science ®Google Scholar
• Goetz CG, Stebbins GT, Klawans HL et al. United Parkinson Foundation Neurotransplantation Registry on adrenal medullary transplants. Neurology41(11), 1719 (1991).
   PubMedGoogle Scholar
• Hurtig H, Joyce J, Sladek JR, Trojanowski JQ. Postmortem analysis of adrenal-medulla-to-caudate autograft in a patient with Parkinson’s disease. Ann. Neurol.25(6), 607–614 (1989).
   PubMedGoogle Scholar
• Date I, Asari S, Ohmoto T. Two-year follow-up study of a patient with Parkinson’s disease and severe motor fluctuations treated by co-grafts of adrenal medulla and peripheral nerve into bilateral caudate nuclei: case report. Neurosurgery37(3), 515–519 (1995).
   PubMedGoogle Scholar
• Watts RL, Subramanian T, Freeman A et al. Effect of stereotaxic intrastriatal cografts of autologous adrenal medulla and peripheral nerve in Parkinson’s disease: two-year follow-up study. Exp. Neurol.147(2), 510–517 (1997).
   PubMed Web of Science ®Google Scholar
• López-Lozano JJ, Bravo G, Abascal J, Brera B, Millan I. Clinical outcome of cotransplantation of peripheral nerve and adrenal medulla in patients with Parkinson’s disease. J. Neurosurg.90(5), 875–882 (1999).
   PubMedGoogle Scholar
• Olson L, Backlund E-O, Ebendal T et al. Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson’s disease: one-year follow-up of first clinical trial. Arch. Neurol.48(4), 373–381 (1991).
   PubMedGoogle Scholar
• Weir EK, López-Barneo J, Buckler KJ, Archer SL. Acute oxygen-sensing mechanisms. N. Engl. J. Med.353(19), 2042–2055 (2005).
   PubMed Web of Science ®Google Scholar
• Lopez-Barneo J, Lopez-Lopez J, Urena J, Gonzalez C. Chemotransduction in the carotid body: K+ current modulated by PO2 in type I chemoreceptor cells. Science241(4865), 580–582 (1988).
   PubMed Web of Science ®Google Scholar
• Ureña J, Fernández-Chacón R, Benot AR, Alvarez de Toledo GA, López-Barneo J. Hypoxia induces voltage-dependent Ca2+ entry and quantal dopamine secretion in carotid body glomus cells. Proc. Natl Acad. Sci. USA91(21), 10208–10211 (1994).
   PubMed Web of Science ®Google Scholar
• Nosrat CA, Tomac A, Lindqvist E et al. Cellular expression of GDNF mRNA suggests multiple functions inside and outside the nervous system. Cell Tissue Res.286(2), 191–207 (1996).
   PubMedGoogle Scholar
• Villadiego J, Mendez-Ferrer S, Valdes-Sanchez T et al. Selective glial cell line-derived neurotrophic factor production in adult dopaminergic carotid body cells in situ and after intrastriatal transplantation. J. Neurosci.25(16), 4091–4098 (2005).
   PubMedGoogle Scholar
• Lin L, Doherty D, Lile J, Bektesh S, Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science260(5111), 1130–1132 (1993).
   PubMed Web of Science ®Google Scholar
• Sinclair SR, Svendsen CN, Torres EM, Martin D, Fawcett JW, Dunnett SB. GDNF enhances dopaminergic cell survival and fibre outgrowth in embryonic nigral grafts. NeuroReport7(15–17), 2547–2552 (1996).
   PubMed Web of Science ®Google Scholar
• Pardal R, Ortega-Sáenz P, Durán R, López-Barneo J. Glia-like stem cells sustain physiologic neurogenesis in the adult mammalian carotid body. Cell131(2), 364–377 (2007).
   PubMed Web of Science ®Google Scholar
• Espejo EF, Montoro RJ, Armengol JA, López-Barneo J. Cellular and functional recovery of Parkinsonian rats after intrastriatal transplantation of carotid body cell aggregates. Neuron20(2), 197–206 (1998).
   PubMed Web of Science ®Google Scholar
• Toledo-Aral JJ, Mendez-Ferrer S, Pardal R, Echevarria M, Lopez-Barneo J. Trophic restoration of the nigrostriatal dopaminergic pathway in long-term carotid body-grafted Parkinsonian rats. J. Neurosci.23(1), 141–148 (2003).
   PubMed Web of Science ®Google Scholar
• Luquin MR, Montoro RJ, Guillén J et al. Recovery of chronic Parkinsonian monkeys by autotransplants of carotid body cell aggregates into putamen. Neuron22(4), 743–750 (1999).
   PubMed Web of Science ®Google Scholar
• Mínguez-Castellanos A, Escamilla-Sevilla F, Hotton GR et al. Carotid body autotransplantation in Parkinson disease: a clinical and positron emission tomography study. J. Neurol. Neurosurg. Psychiatry78(8), 825–831 (2007).
   PubMed Web of Science ®Google Scholar
• Galpern WR, Burns LH, Deacon TW, Dinsmore J, Isacson O. Xenotransplantation of porcine fetal ventral mesencephalon in a rat model of parkinson’s disease: functional recovery and graft morphology. Exp. Neurol.140(1), 1–13 (1996).
   PubMed Web of Science ®Google Scholar
• Barker RA, Ratcliffe E, McLaughlin M, Richards A, Dunnett SB. A role for complement in the rejection of porcine ventral mesencephalic xenografts in a rat model of Parkinson’s disease. J. Neurosci.20(9), 3415–3424 (2000).
   PubMedGoogle Scholar
• Isacson O, Deacon TW, Pakzaban P, Galpern WR, Dinsmore J, Burns LH. Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibres. Nat. Med.1(11), 1189–1194 (1995).
   PubMedGoogle Scholar
• Kuan W-L, Hurelbrink CB, Barker RA. Increased capacity for axonal outgrowth using xenogenic tissue in vitro and in a rodent model of Parkinson’s disease. Xenotransplantation13(3), 233–247 (2006).
   PubMedGoogle Scholar
• Sumitran S, Liu J, Czech KA, Christensson B, Widner H, Holgersson J. Human natural antibodies cytotoxic to pig embryonic brain cells recognize novel non-Galα1,3Gal-based xenoantigens. Exp. Neurol.159(2), 347–361 (1999).
   PubMedGoogle Scholar
• Harrower TP, Richards A, Cruz G, Copeman L, Dunnett SB, Barker RA. α Gal is widely expressed in embryonic porcine stem cells and neural tissue. NeuroReport13(4), 481–485 (2002).
   PubMedGoogle Scholar
• Phelps CJ, Koike C, Vaught TD et al. Production of α1,3-galactosyltransferase-deficient pigs. Science299(5605), 411–414 (2003).
   PubMed Web of Science ®Google Scholar
• Patience C, Takeuchi Y, Weiss RA. Infection of human cells by an endogenous retrovirus of pigs. Nat. Med.3(3), 282–286 (1997).
   PubMed Web of Science ®Google Scholar
• Björklund A, Dunnett SB, Brundin P et al. Neural transplantation for the treatment of Parkinson’s disease. Lancet Neurol.2(7), 437–445 (2003).
   PubMed Web of Science ®Google Scholar
• Schumacher JM, Ellias SA, Palmer EP et al. Transplantation of embryonic porcine mesencephalic tissue in patients with PD. Neurology54(5), 1042–1050 (2000).
   PubMed Web of Science ®Google Scholar
• Deacon T, Schumacher J, Dinsmore J et al. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson’s disease. Nat. Med.3(3), 350–353 (1997).
   PubMed Web of Science ®Google Scholar
• Altman J, Bayer SA. Development of the brain stem in the rat. V. Thymidine-radiographic study of the time of origin of neurons in the midbrain tegmentum. J. Comp. Neurol.198(4), 677–716 (1981).
   PubMed Web of Science ®Google Scholar
• Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science255(5052), 1707–1710 (1992).
   PubMed Web of Science ®Google Scholar
• Svendsen CN, Caldwell MA, Shen J et al. Long-term survival of human central nervous system progenitor cells transplanted into a rat model of Parkinson’s disease. Exp. Neurol.148(1), 135–146 (1997).
   PubMed Web of Science ®Google Scholar
• Studer L, Tabar V, McKay R. Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat. Neurosci.1(4), 290–295 (1998).
   PubMed Web of Science ®Google Scholar
• Yan J, Studer L, McKay RDG. Ascorbic acid increases the yield of dopaminergic neurons derived from basic fibroblast growth factor expanded mesencephalic precursors. J. Neurochem.76(1), 307–311 (2001).
   PubMed Web of Science ®Google Scholar
• Sánchez-Pernaute R, Studer L, Bankiewicz KS, Major EO, McKay RD. In vitro generation and transplantation of precursor-derived human dopamine neurons. J. Neurosci. Res.65(4), 284–288 (2001).
   PubMed Web of Science ®Google Scholar
• Prakash N, Wurst W. Development of dopaminergic neurons in the mammalian brain. Cell. Mol. Life Sci.63(2), 187–206 (2006).
   PubMedGoogle Scholar
• Smidt MP, Burbach JPH. How to make a mesodiencephalic dopaminergic neuron. Nat. Rev. Neurosci.8(1), 21–32 (2007).
   PubMed Web of Science ®Google Scholar
• Hynes M, Poulsen K, Tessier-Lavigne M, Rosenthal A. Control of neuronal diversity by the floor plate: contact-mediated induction of midbrain dopaminergic neurons. Cell80(1), 95–101 (1995).
   PubMed Web of Science ®Google Scholar
• Wang MZ, Jin P, Bumcrot DA, Marigo V et al. Induction of dopaminergic neuron phenotype in the midbrain by Sonic hedgehog protein. Nat. Med.1(11), 1184–1188 (1995).
   PubMed Web of Science ®Google Scholar
• Ye W, Shimamura K, Rubenstein JLR, Hynes MA, Rosenthal A. FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate. Cell93(5), 755–766 (1998).
   PubMed Web of Science ®Google Scholar
• Meyers EN, Lewandoski M, Martin GR. An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat Genet.18(2), 136–141 (1998).
   PubMed Web of Science ®Google Scholar
• Smidt MP, van Schaick HSA, Lancôt C et al. A homeodomain gene Ptx3 has highly restricted brain expression in mesencephalic dopaminergic neurons. Proc. Natl Acad. Sci. USA94(24), 13305–13310 (1997).
   PubMed Web of Science ®Google Scholar
• Zetterström RH, Solomin L, Jansson L, Hoffer BJ, Olson L, Perlmann T. Dopamine neuron agenesis in Nurr1-deficient mice. Science276(5310), 248–250 (1997).
   PubMed Web of Science ®Google Scholar
• Saucedo-Cardenas O, Quintana-Hau JD, Le W-D et al. Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc. Natl Acad. Sci. USA95(7), 4013–4018 (1998).
   PubMed Web of Science ®Google Scholar
• O’Keeffe FE, Scott SA, Tyers P et al. Induction of A9 dopaminergic neurons from neural stem cells improves motor function in an animal model of Parkinson’s disease. Brain131(3), 630–641 (2008).
   PubMed Web of Science ®Google Scholar
• Parish CL, Castelo-Branco G, Rawal N et al. Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice. J. Clin. Invest.118(1), 149–160 (2008).
   PubMedGoogle Scholar
• Andersson EKI, Irvin DK, Ahlsiö J, Parmar M. Ngn2 and Nurr1 act in synergy to induce midbrain dopaminergic neurons from expanded neural stem and progenitor cells. Exp. Cell Res.313(6), 1172–1180 (2007).
   PubMedGoogle Scholar
• Studer L, Csete M, Lee S-H et al. Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J. Neurosci.20(19), 7377–7383 (2000).
   PubMed Web of Science ®Google Scholar
• Krabbe C, Courtois E, Jensen P et al. Enhanced dopaminergic differentiation of human neural stem cells by synergistic effect of Bcl-xL and reduced oxygen tension. J. Neurochem.110(6), 1908–1920 (2009).
   PubMedGoogle Scholar
• Ling ZD, Potter ED, Lipton JW, Carvey PM. Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines. Exp.Neurol.149(2), 411–423 (1998).
   PubMed Web of Science ®Google Scholar
• Potter ED, Ling ZD, Carvey PM. Cytokine-induced conversion of mesencephalic-derived progenitor cells into dopamine neurons. Cell Tissue Res.296(2), 235–246 (1999).
   PubMed Web of Science ®Google Scholar
• Carvey PM, Ling ZD, Sortwell CE et al. A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson’s disease. Exp. Neurol.171(1), 98–108 (2001).
   PubMedGoogle Scholar
• Courtois ET, Castillo CG, Seiz EG et al. In vitro and in vivo enhanced generation of human A9 dopamine neurons from neural stem cells by Bcl-xL. J. Biol. Chem.285(13), 9881–9897 (2010).
   PubMed Web of Science ®Google Scholar
• Young A, Assey KS, Sturkie CD, West FD, Machacek DW, Stice SL. Glial cell line-derived neurotrophic factor enhances in vitro differentiation of mid-/hindbrain neural progenitor cells to dopaminergic-like neurons. J. Neurosci. Res.88(15), 3222–3232 (2010).
   PubMedGoogle Scholar
• Rößler R, Boddeke E, Copray S. Differentiation of non-mesencephalic neural stem cells towards dopaminergic neurons. Neuroscience170(2), 417–428 (2010).
   PubMedGoogle Scholar
• Donaldson AE, Marshall CE, Yang M, Suon S, Iacovitti L. Purified mouse dopamine neurons thrive and function after transplantation into brain but require novel glial factors for survival in culture. Mol. Cell. Neurosci.30(1), 108–117 (2005).
   PubMedGoogle Scholar
• Hedlund E, Pruszak J, Lardaro T et al. Embryonic stem cell-derived Pitx3-enhanced green fluorescent protein midbrain dopamine neurons survive enrichment by fluorescence-activated cell sorting and function in an animal model of Parkinson’s disease. Stem Cells26(6), 1526–1536 (2008).
   PubMed Web of Science ®Google Scholar
• Jain M, Armstrong RJE, Tyers P, Barker RA, Rosser AE. GABAergic immunoreactivity is predominant in neurons derived from expanded human neural precursor cells in vitro. Exp. Neurol.182(1), 113–123 (2003).
   PubMed Web of Science ®Google Scholar
• Chung S, Shin BS, Hwang M et al. Neural precursors derived from embryonic stem cells, but not those from fetal ventral mesencephalon, maintain the potential to differentiate into dopaminergic neurons after expansion in vitro. Stem Cells24(6), 1583–1593 (2006).
   PubMedGoogle Scholar
• Jensen P, Pedersen EG, Zimmer J, Widmer HR, Meyer M. Functional effect of FGF2- and FGF8-expanded ventral mesencephalic precursor cells in a rat model of Parkinson’s disease. Brain Res.1218, 13–20 (2008).
   PubMedGoogle Scholar
• Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature292(5819), 154–156 (1981).
   PubMed Web of Science ®Google Scholar
• Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl Acad. Sci. USA78(12), 7634–7638 (1981).
   PubMed Web of Science ®Google Scholar
• Thomson JA, Kalishman J, Golos TG et al. Isolation of a primate embryonic stem cell line. Proc. Natl Acad. Sci. USA92(17), 7844–7848 (1995).
   PubMed Web of Science ®Google Scholar
• Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science282(5391), 1145–1147 (1998).
   PubMed Web of Science ®Google Scholar
• Park S, Lee KS, Lee YJ et al. Generation of dopaminergic neurons in vitro from human embryonic stem cells treated with neurotrophic factors. Neurosci. Lett.359(1–2), 99–103 (2004).
   PubMed Web of Science ®Google Scholar
• Perrier AL, Tabar V, Barberi T et al. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc. Natl Acad. Sci. USA101(34), 12543–12548 (2004).
   PubMed Web of Science ®Google Scholar
• Lee S-H, Lumelsky N, Studer L, Auerbach JM, McKay RD. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat. Biotech.18(6), 675–679 (2000).
   PubMed Web of Science ®Google Scholar
• Cho MS, Lee Y-E, Kim JY et al. Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells. Proc. Natl Acad. Sci. USA105(9), 3392–3397 (2008).
   PubMed Web of Science ®Google Scholar
• Cho M-S, Hwang D-Y, Kim D-W. Efficient derivation of functional dopaminergic neurons from human embryonic stem cells on a large scale. Nat. Protocols3(12), 1888–1894 (2008).
   PubMed Web of Science ®Google Scholar
• Kim J-H, Auerbach JM, Rodriguez-Gomez JA et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson’s disease. Nature418(6893), 50–56 (2002).
   PubMed Web of Science ®Google Scholar
• Zhang Z-J, Yang D, Oldenburg M, Ayala M, Zhang S-C. Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in Parkinsonian rats. Stem Cells26(1), 55–63 (2008).
   PubMedGoogle Scholar
• Ben-Hur T, Idelson M, Khaner H et al. Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in parkinsonian rats. Stem Cells22(7), 1246–1255 (2004).
   PubMed Web of Science ®Google Scholar
• Brederlau A, Correia AS, Anisimov SV et al. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson’s disease: effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells24(6), 1433–1440 (2006).
   PubMed Web of Science ®Google Scholar
• Kim D, Kim C-H, Moon J-I, Chung Y-G et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell4(6), 472–476 (2009).
   PubMed Web of Science ®Google Scholar
• Jönsson ME, Ono Y, Björklund A, Thompson LH. Identification of transplantable dopamine neuron precursors at different stages of midbrain neurogenesis. Exp. Neurol.219(1), 341–354 (2009).
   PubMed Web of Science ®Google Scholar
• Amit M, Carpenter MK, Inokuma MS et al. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev. Biol.227(2), 271–278 (2000).
   PubMed Web of Science ®Google Scholar
• Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. J. Neurosci. Res.61(4), 364–370 (2000).
   PubMed Web of Science ®Google Scholar
• Woodbury D, Reynolds K, Black IB. Adult bone marrow stromal stem cells express germline, ectodermal, endodermal, and mesodermal genes prior to neurogenesis. J. Neurosci. Res.69(6), 908–917 (2002).
   PubMed Web of Science ®Google Scholar
• Sanchez-Ramos J, Song S, Cardozo-Pelaez F et al. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp. Neurol.164(2), 247–256 (2000).
   PubMed Web of Science ®Google Scholar
• Munoz-Elias G, Marcus AJ, Coyne TM, Woodbury D, Black IB. Adult bone marrow stromal cells in the embryonic brain: engraftment, migration, differentiation, and long-term survival. J. Neurosci.24(19), 4585–4595 (2004).
   PubMed Web of Science ®Google Scholar
• Li Y, Chen J, Wang L, Zhang L, Lu M, Chopp M. Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease. Neurosci. Lett.316(2), 67–70 (2001).
   PubMed Web of Science ®Google Scholar
• Dezawa M, Kanno H, Hoshino M et al. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J. Clin. Invest.113(12), 1701–1710 (2004).
   PubMed Web of Science ®Google Scholar
• Offen D, Barhum Y, Levy YS et al. Intrastriatal transplantation of mouse bone marrow-derived stem cells improves motor behavior in a mouse model of Parkinson’s disease. In: Neuropsychiatric Disorders: An Integrative Approach. Gerlach M, Deckert J, Double K, Koutsilieri E (Eds). Springer, Vienna, Austria, 133–143 (2007).
   Google Scholar
• Jin G-Z, Cho S-J, Choi E-G et al. Rat mesenchymal stem cells increase tyrosine hydroxylase expression and dopamine content in ventral mesencephalic cells in vitro. Cell Biol. Int.32(11), 1433–1438 (2008).
   PubMedGoogle Scholar
• Bouchez G, Sensebé L, Vourc’h P et al. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson’s disease. Neurochem. Int.52(7), 1332–1342 (2008).
   PubMed Web of Science ®Google Scholar
• Fumagalli F, Racagni G, Riva MA. Shedding light into the role of BDNF in the pharmacotherapy of Parkinson’s disease. Pharmacogenomics J.6(2), 95–104 (2006).
   PubMed Web of Science ®Google Scholar
• Björklund A, Rosenblad C, Winkler C, Kirik D. Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson’s disease. Neurobiol. Dis.4(3–4), 186–200 (1997).
   PubMed Web of Science ®Google Scholar
• Wang F, Yasuhara T, Shingo T et al. Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1α. BMC Neurosci.11(1), 52 (2010).
   PubMed Web of Science ®Google Scholar
• Venkataramana NK, Kumar SKV, Balaraju S et al. Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson’s disease. Transl. Res.155(2), 62–70 (2010).
   PubMed Web of Science ®Google Scholar
• Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell126(4), 663–676 (2006).
   PubMed Web of Science ®Google Scholar
• Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, Lovell-Badge R. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev.17(1), 126–140 (2003).
   PubMed Web of Science ®Google Scholar
• Nichols J, Zevnik B, Anastassiadis K et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell95(3), 379–391 (1998).
   PubMed Web of Science ®Google Scholar
• Niwa H, Miyazaki J-I, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet.24(4), 372–376 (2000).
   PubMed Web of Science ®Google Scholar
• Li Y, McClintick J, Zhong L, Edenberg HJ, Yoder MC, Chan RJ. Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4. Blood105(2), 635–637 (2005).
   PubMed Web of Science ®Google Scholar
• Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell131(5), 861–872 (2007).
   PubMed Web of Science ®Google Scholar
• Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science318(5858), 1917–1920 (2007).
   PubMed Web of Science ®Google Scholar
• Nakagawa M, Koyanagi M, Tanabe K et al. Generation of induced pluripotent stem cells without myc from mouse and human fibroblasts. Nat. Biotech.26(1), 101–106 (2008).
   PubMed Web of Science ®Google Scholar
• Soldner F, Hockemeyer D, Beard C et al. Parkinson’s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell136(5), 964–977 (2009).
   PubMed Web of Science ®Google Scholar
• Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature458(7239), 771–775 (2009).
   PubMed Web of Science ®Google Scholar
• Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science322(5903), 945–949 (2008).
   PubMed Web of Science ®Google Scholar
• Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science322(5903), 949–953 (2008).
   PubMed Web of Science ®Google Scholar
• Woltjen K, Michael IP, Mohseni P et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature458(7239), 766–770 (2009).
   PubMed Web of Science ®Google Scholar
• Zhou H, Wu S, Joo JY et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell.4(5), 381–384 (2009).
   PubMed Web of Science ®Google Scholar
• Jia F, Wilson KD, Sun N et al. A nonviral minicircle vector for deriving human iPS cells. Nat. Methods7(3), 197–199 (2010).
   PubMed Web of Science ®Google Scholar
• Wernig M, Zhao J-P, Pruszak J et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson’s disease. Proc. Natl Acad. Sci. USA105(15), 5856–5861 (2008).
   PubMed Web of Science ®Google Scholar
• Swistowski A, Peng J, Liu Q et al. Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions. Stem Cells28(10), 1893–1904 (2010).
   PubMed Web of Science ®Google Scholar
• Cai J, Yang M, Poremsky E, Kidd S, Schneider JS, Iacovitti L. Dopaminergic neurons derived from human induced pluripotent stem cells survive and integrate into 6-OHDA-lesioned rats. Stem Cells Dev.19(7), 1017–1023 (2010).
   PubMed Web of Science ®Google Scholar
• Soldner F, Hockemeyer D, Beard C et al. Parkinson’s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. 136(5), 964–977 (2009).
   Google Scholar
• Hargus G, Cooper O, Deleidi M et al. Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc. Natl Acad. Sci. USA107(36), 15921–15926 (2010).
   PubMed Web of Science ®Google Scholar
• Park I-H, Arora N, Huo H et al. Disease-specific induced pluripotent stem cells. Cell134(5), 877–886 (2008).
   PubMed Web of Science ®Google Scholar
• Urnov FD, Miller JC, Lee Y-L et al. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature435(7042), 646–651 (2005).
   PubMed Web of Science ®Google Scholar
• Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, Südhof TC, Wernig M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature463(7284), 1035–1041 (2010).
   PubMed Web of Science ®Google Scholar
• Schultzberg M, Dunnett SB, Björklund A et al. Dopamine and cholecystokinin immunoreactive neurones in mesencephalic grafts reinnervating the neostriatum: evidence for selective growth regulation. Neuroscience12(1), 17–32 (1984).
   PubMedGoogle Scholar
• Grealish S, Jonsson ME, Li M, Kirik D, Bjorklund A, Thompson LH. The A9 dopamine neuron component in grafts of ventral mesencephalon is an important determinant for recovery of motor function in a rat model of Parkinson’s disease. Brain133(2), 482–495 (2010).
   PubMed Web of Science ®Google Scholar
• Krack P, Pollak P, Limousin P, Benazzouz A, Benabid AL. Stimulation of subthalamic nucleus alleviates tremor in Parkinson’s disease. Lancet350(9092), 1675 (1997).
   PubMed Web of Science ®Google Scholar
• Vingerhoets FJG, Villemure J-G, Temperli P, Pollo C, Pralong E, Ghika J. Subthalamic DBS replaces levodopa in Parkinson’s disease. Neurology58(3), 396–401 (2002).
   PubMed Web of Science ®Google Scholar
• Krack P, Batir A, Van Blercom N et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N. Engl. J. Med.349(20), 1925–1934 (2003).
   PubMed Web of Science ®Google Scholar
• Le Jeune F, Drapier D, Bourguignon A et al. Subthalamic nucleus stimulation in Parkinson disease induces apathy. Neurology73(21), 1746–1751 (2009).
   PubMed Web of Science ®Google Scholar
• Hershey T, Revilla FJ, Wernle A, Gibson PS, Dowling JL, Perlmutter JS. Stimulation of STN impairs aspects of cognitive control in PD. Neurology62(7), 1110–1114 (2004).
   PubMed Web of Science ®Google Scholar
• Mallet L, Schüpbach M, N’Diaye K et al. Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior. Proc. Natl Acad. Sci. USA104(25), 10661–10666 (2007).
   PubMed Web of Science ®Google Scholar
• Voon V, Krack P, Lang AE et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson’s disease. Brain131(10), 2720–2728 (2008).
   PubMed Web of Science ®Google Scholar
• Li J-Y, Englund E, Holton JL et al. Lewy bodies in grafted neurons in subjects with Parkinson’s disease suggest host-to-graft disease propagation. Nat. Med.14(5), 501–503 (2008).
   PubMed Web of Science ®Google Scholar
• Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson’s disease. Nat. Med.14(5), 504–506 (2008).
   PubMed Web of Science ®Google Scholar
• Mendez I, Vinuela A, Astradsson A et al. Dopamine neurons implanted into people with Parkinson’s disease survive without pathology for 14 years. Nat. Med.14(5), 507–509 (2008).
   PubMed Web of Science ®Google Scholar
• Anderson L, Caldwell MA. Human neural progenitor cell transplants into the subthalamic nucleus lead to functional recovery in a rat model of Parkinson’s disease. Neurobiol. Dis.27(2), 133–140 (2007).
   PubMedGoogle Scholar